MELBOURNE, AUSTRALIA--(Marketwire - July 22, 2008) - Prana Biotechnology Limited (NASDAQ: PRAN) (ASX: PBT), a biopharmaceutical company focused on the research and development of treatments for neurodegenerative disorders, announced today that the Company will be hosting a conference call with Geoffrey Kempler, Chairman and CEO, and Dr. Jeffrey Cummings, Chairman of Prana's Research and Development Advisory Board, on July 31, 2008 at noon EDT (USA time).
